Robert James Rudelius - Net Worth and Insider Trading
Robert James Rudelius Net Worth
The estimated net worth of Robert James Rudelius is at least $402,579 dollars as of 2024-11-13. Robert James Rudelius is the Director of Axogen Inc and owns about 23,273 shares of Axogen Inc (AXGN) stock worth over $300,687. Robert James Rudelius is also the Director of PetVivo Holdings Inc and owns about 208,611 shares of PetVivo Holdings Inc (PETV) stock worth over $101,892. Details can be seen in Robert James Rudelius's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert James Rudelius has not made any transactions after 2022-11-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert James Rudelius
Robert James Rudelius Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert James Rudelius owns 2 companies in total, including Axogen Inc (AXGN) , and PetVivo Holdings Inc (PETV) .
Click here to see the complete history of Robert James Rudelius’s form 4 insider trades.
Insider Ownership Summary of Robert James Rudelius
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AXGN | Axogen Inc | 2017-09-11 | director |
PETV | PetVivo Holdings Inc | 2022-11-21 | director |
Robert James Rudelius Latest Holdings Summary
Robert James Rudelius currently owns a total of 2 stocks. Among these stocks, Robert James Rudelius owns 23,273 shares of Axogen Inc (AXGN) as of September 11, 2017, with a value of $300,687 and a weighting of 74.69%. Robert James Rudelius also owns 208,611 shares of PetVivo Holdings Inc (PETV) as of November 21, 2022, with a value of $101,892 and a weighting of 25.31%.
Latest Holdings of Robert James Rudelius
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AXGN | Axogen Inc | 2017-09-11 | 23,273 | 12.92 | 300,687 |
PETV | PetVivo Holdings Inc | 2022-11-21 | 208,611 | 0.49 | 101,892 |
Holding Weightings of Robert James Rudelius
Robert James Rudelius Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert James Rudelius has made a total of 0 transactions in Axogen Inc (AXGN) over the past 5 years. The most-recent trade in Axogen Inc is the sale of 16,143 shares on September 11, 2017, which brought Robert James Rudelius around $290,574.
According to the SEC Form 4 filings, Robert James Rudelius has made a total of 2 transactions in PetVivo Holdings Inc (PETV) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in PetVivo Holdings Inc is the acquisition of 860 shares on November 21, 2022, which cost Robert James Rudelius around $2,279.
Insider Trading History of Robert James Rudelius
- 1
Robert James Rudelius Trading Performance
GuruFocus tracks the stock performance after each of Robert James Rudelius's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert James Rudelius is 20.32%. GuruFocus also compares Robert James Rudelius's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert James Rudelius within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert James Rudelius's insider trading performs compared to the benchmark.
Performance of Robert James Rudelius
Robert James Rudelius Ownership Network
Ownership Network List of Robert James Rudelius
Ownership Network Relation of Robert James Rudelius
Robert James Rudelius Owned Company Details
What does Axogen Inc do?
Who are the key executives at Axogen Inc?
Robert James Rudelius is the director of Axogen Inc. Other key executives at Axogen Inc include Chief R&D Officer Angelo Scopelianos , director & CEO Karen L. Zaderej , and VP & Clinical&Translational Sc Erick Wayne Devinney .
Axogen Inc (AXGN) Insider Trades Summary
Over the past 18 months, Robert James Rudelius made no insider transaction in Axogen Inc (AXGN). Other recent insider transactions involving Axogen Inc (AXGN) include a net sale of 74,448 shares made by Gregory Gene Freitag , a net sale of 42,343 shares made by Michael Patrick Donovan , and a net sale of 39,280 shares made by Karen L. Zaderej .
In summary, during the past 3 months, insiders sold 0 shares of Axogen Inc (AXGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 180,030 shares of Axogen Inc (AXGN) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 150,030 shares.
Axogen Inc (AXGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Axogen Inc Insider Transactions
Robert James Rudelius Mailing Address
Above is the net worth, insider trading, and ownership report for Robert James Rudelius. You might contact Robert James Rudelius via mailing address: 6913 Arbor Lane, Mcclean Va 22101.